Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?

J Clin Oncol. 2017 Jun 1;35(16):1858-1859. doi: 10.1200/JCO.2016.71.6506. Epub 2017 Mar 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anilides
  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Neoplasms*
  • Pyridines
  • Sunitinib

Substances

  • Anilides
  • Pyridines
  • cabozantinib
  • Sunitinib